Steven Cohen's RCKT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.01 M shares of Rocket Pharmaceuticals, Inc. (RCKT) worth $3.62 M, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in RCKT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2024, adding 1.52 M shares. Largest reduction occurred in Q1 2025, reducing 1.57 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Rocket Pharmaceuticals (RCKT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rocket Pharmaceuticals (RCKT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +504,217 | Add 99.27% | 1.01 M | $3.58 |
| Q4 2025 | +507,909 | New Buy | 507,909 | $3.51 |
| Q1 2025 | -1.57 M | Sold Out | 0 | $0.00 |
| Q4 2024 | +1.52 M | Add 3163.94% | 1.57 M | $12.57 |
| Q3 2024 | +48,096 | New Buy | 48,096 | $18.47 |
Steven Cohen's Rocket Pharmaceuticals Investment FAQs
Steven Cohen first purchased Rocket Pharmaceuticals, Inc. (RCKT) in Q3 2024, acquiring 48,096 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Rocket Pharmaceuticals, Inc. (RCKT) for 5 quarters since Q3 2024.
Steven Cohen's largest addition to Rocket Pharmaceuticals, Inc. (RCKT) was in Q4 2024, adding 1,569,823 shares worth $19.73 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,012,126 shares of Rocket Pharmaceuticals, Inc. (RCKT), valued at approximately $3.62 M.
As of the Q1 2026 filing, Rocket Pharmaceuticals, Inc. (RCKT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Rocket Pharmaceuticals, Inc. (RCKT) was 1,569,823 shares, as reported at the end of Q4 2024.